Toxicity and supportive care requirements of induction courses 1 and 2
| . | Course 1 . | Course 2 . | ||||
|---|---|---|---|---|---|---|
| DAT . | ADE . | MAC . | DAT . | ADE . | MAC . | |
| Hematologic toxicity, median days from end of course to | ||||||
| Neutrophils, more than 1.0 × 109/L | 20 | 19 | 24 | 19 | 18 | 22 |
| Platelets, more than 100 × 109/L | 21 | 22 | 22 | 20 | 19 | 20 |
| Nonhematologic toxicity, mean World Health Organization grade | ||||||
| Nausea/vomiting | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 0.8 |
| Alopecia | 2.0 | 2.0 | 1.8 | 2.7 | 2.6 | 2.3 |
| Oral toxicity | 1.1 | 1.2 | 0.9 | 0.6 | 0.8 | 0.7 |
| Diarrhea | 1.0 | 1.2 | 0.6 | 0.5 | 0.6 | 0.4 |
| Cardiac function | 0.4 | 0.4 | 0.3 | 0.1 | 0.2 | 0.1 |
| Supportive care | ||||||
| Units of blood, mean | 12 | 12 | 11 | 5 | 6 | 6 |
| Units of platelets, mean | 51 | 48 | 39 | 18 | 21 | 22 |
| Days on IV antibiotics, mean | 20 | 20 | 18 | 8 | 12 | 11 |
| Days in hospital, median | 28 | 27 | 25 | 20 | 21 | 22 |
| . | Course 1 . | Course 2 . | ||||
|---|---|---|---|---|---|---|
| DAT . | ADE . | MAC . | DAT . | ADE . | MAC . | |
| Hematologic toxicity, median days from end of course to | ||||||
| Neutrophils, more than 1.0 × 109/L | 20 | 19 | 24 | 19 | 18 | 22 |
| Platelets, more than 100 × 109/L | 21 | 22 | 22 | 20 | 19 | 20 |
| Nonhematologic toxicity, mean World Health Organization grade | ||||||
| Nausea/vomiting | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 0.8 |
| Alopecia | 2.0 | 2.0 | 1.8 | 2.7 | 2.6 | 2.3 |
| Oral toxicity | 1.1 | 1.2 | 0.9 | 0.6 | 0.8 | 0.7 |
| Diarrhea | 1.0 | 1.2 | 0.6 | 0.5 | 0.6 | 0.4 |
| Cardiac function | 0.4 | 0.4 | 0.3 | 0.1 | 0.2 | 0.1 |
| Supportive care | ||||||
| Units of blood, mean | 12 | 12 | 11 | 5 | 6 | 6 |
| Units of platelets, mean | 51 | 48 | 39 | 18 | 21 | 22 |
| Days on IV antibiotics, mean | 20 | 20 | 18 | 8 | 12 | 11 |
| Days in hospital, median | 28 | 27 | 25 | 20 | 21 | 22 |
For abbreviations, see Table 1.